284 related articles for article (PubMed ID: 29118091)
1. Structure-based drug design: aiming for a perfect fit.
van Montfort RLM; Workman P
Essays Biochem; 2017 Nov; 61(5):431-437. PubMed ID: 29118091
[TBL] [Abstract][Full Text] [Related]
2. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
[TBL] [Abstract][Full Text] [Related]
3. NMR in structure-based drug design.
Carneiro MG; Ab E; Theisgen S; Siegal G
Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application.
Scapin G; Potter CS; Carragher B
Cell Chem Biol; 2018 Nov; 25(11):1318-1325. PubMed ID: 30100349
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery in the era of cryo-electron microscopy.
Robertson MJ; Meyerowitz JG; Skiniotis G
Trends Biochem Sci; 2022 Feb; 47(2):124-135. PubMed ID: 34281791
[TBL] [Abstract][Full Text] [Related]
6. An outlook on using serial femtosecond crystallography in drug discovery.
Mishin A; Gusach A; Luginina A; Marin E; Borshchevskiy V; Cherezov V
Expert Opin Drug Discov; 2019 Sep; 14(9):933-945. PubMed ID: 31184514
[No Abstract] [Full Text] [Related]
7. Mass spectrometry for fragment screening.
Chan DS; Whitehouse AJ; Coyne AG; Abell C
Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
[TBL] [Abstract][Full Text] [Related]
8. Cryo-electron microscopy-based drug design.
Cebi E; Lee J; Subramani VK; Bak N; Oh C; Kim KK
Front Mol Biosci; 2024; 11():1342179. PubMed ID: 38501110
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities for new protein crystallization strategies in structure-based drug design.
Grey JL; Thompson DH
Expert Opin Drug Discov; 2010 Nov; 5(11):1039-45. PubMed ID: 21116481
[TBL] [Abstract][Full Text] [Related]
10. Use of molecular docking computational tools in drug discovery.
Stanzione F; Giangreco I; Cole JC
Prog Med Chem; 2021; 60():273-343. PubMed ID: 34147204
[TBL] [Abstract][Full Text] [Related]
11. Protein structure-based drug design: from docking to molecular dynamics.
Śledź P; Caflisch A
Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
[TBL] [Abstract][Full Text] [Related]
12. Essential considerations for using protein-ligand structures in drug discovery.
Warren GL; Do TD; Kelley BP; Nicholls A; Warren SD
Drug Discov Today; 2012 Dec; 17(23-24):1270-81. PubMed ID: 22728777
[TBL] [Abstract][Full Text] [Related]
13. Cryo-electron microscopy and X-ray crystallography: complementary approaches to structural biology and drug discovery.
Vénien-Bryan C; Li Z; Vuillard L; Boutin JA
Acta Crystallogr F Struct Biol Commun; 2017 Apr; 73(Pt 4):174-183. PubMed ID: 28368275
[TBL] [Abstract][Full Text] [Related]
14. Membrane protein crystallography in the era of modern structural biology.
Kwan TOC; Axford D; Moraes I
Biochem Soc Trans; 2020 Dec; 48(6):2505-2524. PubMed ID: 33170253
[TBL] [Abstract][Full Text] [Related]
15. Practices in Molecular Docking and Structure-Based Virtual Screening.
Dos Santos RN; Ferreira LG; Andricopulo AD
Methods Mol Biol; 2018; 1762():31-50. PubMed ID: 29594766
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Structure-Based Drug Design (HT-SBDD) Using Drug Docking, Fragment Molecular Orbital Calculations, and Molecular Dynamic Techniques.
Martin RL; Heifetz A; Bodkin MJ; Townsend-Nicholson A
Methods Mol Biol; 2024; 2716():293-306. PubMed ID: 37702945
[TBL] [Abstract][Full Text] [Related]
17. The critical role of QM/MM X-ray refinement and accurate tautomer/protomer determination in structure-based drug design.
Borbulevych OY; Martin RI; Westerhoff LM
J Comput Aided Mol Des; 2021 Apr; 35(4):433-451. PubMed ID: 33108589
[TBL] [Abstract][Full Text] [Related]
18. The future of crystallography in drug discovery.
Zheng H; Hou J; Zimmerman MD; Wlodawer A; Minor W
Expert Opin Drug Discov; 2014 Feb; 9(2):125-37. PubMed ID: 24372145
[TBL] [Abstract][Full Text] [Related]
19. Development of a rule-based method for the assessment of protein druggability.
Perola E; Herman L; Weiss J
J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
[TBL] [Abstract][Full Text] [Related]
20. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
